Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07565571

Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations

High-achieving academic and entrepreneurial populations face elevated risks of chronic stress, anxiety, and burnout. These populations often underutilize mental health services due to stigma, time constraints, or accessibility issues. Digital interventions provide an opportunity to deliver evidence-based stress and resilience support at scale.

The WONE (Walking on Earth, Ltd.) platform integrates personalized stress-resilience assessments, behavioral science micro-interventions, and optional wearable data feedback. This project aims to evaluate the feasibility, engagement, and preliminary efficacy of the WONE digital intervention in multiple Stanford-affiliated cohorts.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford School of Medicine

Stanford, California, 94305, United States

About this study

Primary Objective To evaluate whether engagement with the WONE app improves resilience, emotional well-being, and stress management outcomes among Stanford-affiliated adults.

Secondary Objective To evaluate the feasibility of wearable-device integration.

Rationale for Two-Phase Structure This protocol includes two sequential studies.

  • Phase 1 (Pilot): A single-arm feasibility pilot designed to assess acceptability of the WONE digital intervention, verify that onboarding, survey workflows, and data capture function smoothly, and identify any usability issues before running a randomized trial.
  • Phase 2 (Randomized Crossover RCT): A fully powered evaluation of the efficacy of WONE, using a 12-week crossover design to compare intervention vs. control periods, followed by a 6-month follow-up to evaluate maintenance of effects.

Phase 1 Objectives (Pilot)

  • Assess feasibility and acceptability of the WONE digital intervention over 8 weeks.
  • Evaluate preliminary changes in resilience, emotional well-being, and stress management from baseline to Week 8. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
  • Describe engagement patterns and examine whether engagement relates to changes in outcomes.
  • Assess feasibility of wearable integration, including connection rates and data completeness.

Phase 2 Objectives (Randomized Crossover RCT)

  • Test the efficacy of the WONE intervention compared to a control period using a 12-week crossover design.
  • Examine changes in resilience, emotional well-being, and stress management across intervention vs. control phases. Secondary analysis will also explore changes in symptoms related to anxiety and depression.
  • Investigate engagement as a predictor of improvement.
  • Evaluate maintenance of effects at the 6-month follow-up.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18 and 65 years with Stanford affiliation
  • English proficiency with the ability to read, write, and complete surveys in English
  • Smartphone with internet access
  • Willingness to complete surveys and app activities
  • Resides in the US
  • Stanford affiliation
  • Wearable device for Phase 1 Pilot Study

Exclusion criteria

  • Severe psychiatric instability, defined as any of the following self-reported on the pre-enrollment screener:
  • Psychiatric hospitalization for a mental health crisis in the past 12 months.
  • Current mental health symptoms that significantly impair ability to function in daily life (e.g., unable to work, attend school, or care for basic needs).
  • No smartphone or unwilling to consent.

Treatment and study plan

Intervention WONE App (full Version)

Behavioral

The Intervention WONE app (Full version) has the following features:

  • AI coaching for personalized support
  • Educational articles
  • Live sessions
  • On-demand session recordings
  • WONE Index assessment and tracking
  • Wearable device connection (optional) and wearable-derived scores and metrics The control WONE app (limited version) has no above features, only has push notifications for participants to complete assessments.

Primary outcomes

  1. Phase 1: Change in Walking on Earth Index (WONE) Index

    Time frame: Baseline, week 4, week 8

    WONE index is a 50-item validated measure of psychosocial resilience, recently validated against the Connor-Davidson Resilience Scale and the Brief Resilience Scale.

    Higher scores indicate greater resilience and well-being.

  2. Phase 2: Change in WONE Index

    Time frame: Baseline, week 4, week 8, week 12, week 16, week 20, week 24

    WONE index is a 50-item validated measure of psychosocial resilience. Higher scores indicate greater resilience and well-being.

Study contacts

Contact information is provided by the study sponsor or research team.

Alan Yeung, MD

CONTACT

[email protected]

6507282619

Chloe Yeung

CONTACT

[email protected]

6502450094

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • Walking on Earth Ltd.

Registry information

Official study title

Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations (SIER Study)

Acronym: SIER-WONE

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 4, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.